Anti-HER2, mouse monoclonal, 1 mL, Species x-Reactivity: human, Applications: IHC

HER2

Cat#: BSH-7182-100 100ul, BSH-7182-1 1ml, BSH-7182-RTU 7ml
Clone: BS2
S/R: human
Application: IHC

ERBB2: v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian). This gene encodes a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. This protein has no ligand binding domain of its own and therefore cannot bind growth factors. However, it does bind tightly to other ligand-bound EGF receptor family members to form a heterodimer, stabilizing ligand binding and enhancing kinase-mediated activation of downstream signalling pathways, such as those involving mitogen-activated protein kinase and phosphatidylinositol-3 kinase. Allelic variations at amino acid positions 654 and 655 of isoform a (positions 624 and 625 of isoform b) have been reported, with the most common allele, Ile654/Ile655, shown here. Amplification and/or overexpression of this gene has been reported in numerous cancers, including breast and ovarian tumors. Alternative splicing results in several additional transcript variants, some encoding different isoforms and others that have not been fully characterized.

HER2 stained tissue sections. HER2 positive ductal breast carcinoma (strong) (a, b), HER2 positive ductal breast carcinoma (weak) (c) and HER2 negative ductal breast cancer.